These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14253979)

  • 1. [NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS].
    HIRSCHMANN J; MAYER K
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:599-601. PubMed ID: 14253979
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)].
    HIRSCHMANN J; MAYER K
    Dtsch Med Wochenschr; 1964 Oct; 89():1877-80. PubMed ID: 14211843
    [No Abstract]   [Full Text] [Related]  

  • 3. ELECTROPHYSIOLOGICAL STUDIES IN STEREOTAXIC SURGERY FOR EXTRAPYRAMIDAL DISORDERS. 3. MECHANISM OF PARKINSONIAN TREMOR.
    JINNAI D; NISHIMOTO A; NUMOTO M; ADACHI I
    Confin Neurol; 1964; 24():289-300. PubMed ID: 14204909
    [No Abstract]   [Full Text] [Related]  

  • 4. [PATHOGENESIS OF THE BASIC SYMPTOMS OF PARKINSONISM DUE TO BIOCHEMICAL CHANGES IN THE SUBCORTICAL AND STEM STRUCTURES OF THE EXTRAPYRAMIDAL SYSTEM].
    TRAVENEC I
    Cas Lek Cesk; 1964 Jun; 103():748-52. PubMed ID: 14180121
    [No Abstract]   [Full Text] [Related]  

  • 5. [PATHOGENESIS OF THE BASIC SYMPTOMS OF PARKINSONISM DUE TO BIOCHEMICAL CHANGES IN THE SUBCORTICAL AND STEM STRUCTURES OF THE EXTRAPYRAMIDAL SYSTEM].
    TRAVENED I
    Cas Lek Cesk; 1964 Jun; 103():748-52. PubMed ID: 14178689
    [No Abstract]   [Full Text] [Related]  

  • 6. ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.
    MCGEER PL; ZELDOWICZ LR
    Can Med Assoc J; 1964 Feb; 90(7):463-6. PubMed ID: 14120951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stereotactic brain operations for the treatment of extrapyramidal movement disorders (parkinsonism and hyperkinesias) and their results].
    MUNDINGER F; RIECHERT T
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Jan; 31():1-65 contd. PubMed ID: 13936606
    [No Abstract]   [Full Text] [Related]  

  • 8. [The stereotactic brain operations for the treatment of extrapyramidal movement disorders (parkinsonism and hyperkinesias) and their results].
    MUNDINGER F; RIECHERT T
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Feb; 31():69-120 concl. PubMed ID: 13936605
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF ETHYBENZATROPINE ON EXTRAPYRAMIDAL SYNDROMES AND ABNORMAL MOVEMENTS].
    SIGWALD J; RAVERDY P; PIOT C
    Presse Med (1893); 1963 Dec; 71():2643-4. PubMed ID: 14102418
    [No Abstract]   [Full Text] [Related]  

  • 10. [OBSERVATIONS ON 140 SCHIZOPHRENICS TREATED WITH FLUPHENAZINE. WITH SPECIAL REFERENCE TO DRUG-INDUCED EXTRAPYRAMIDAL SYNDROMES].
    KRUSE W
    Nervenarzt; 1963 Jun; 34():276-80. PubMed ID: 14160709
    [No Abstract]   [Full Text] [Related]  

  • 11. CAMPOTOMY IN VARIOUS EXTRAPYRAMIDAL DISORDERS.
    SPIEGEL EA; WYCIS HT; SZEKELY EG; ADAMS DJ; FLANAGAN M; BAIRD HW
    J Neurosurg; 1963 Oct; 20():871-84. PubMed ID: 14186082
    [No Abstract]   [Full Text] [Related]  

  • 12. A QUANTITATIVE SIMOLA TEST AND ITS APPLICATION TO THE INVESTIGATION OF EXTRAPYRAMIDAL SYNDROMES.
    CURZON G; WALD I
    Clin Chim Acta; 1963 Nov; 8():893-901. PubMed ID: 14089561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
    Radouco-Thomas S
    Laval Med; 1970 Sep; 41(7):886-93. PubMed ID: 5515480
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL MEDICINE AND THE PROBLEM OF SPASTICITY].
    PINELLI P
    Riv Sper Freniatr Med Leg Alien Ment; 1963 Jun; 87():623-38. PubMed ID: 14055518
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Quattroccolo G; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):62-6. PubMed ID: 5524934
    [No Abstract]   [Full Text] [Related]  

  • 16. A CLINICAL AND METABOLIC STUDY OF DOPA (3, 4-DIHYDROXYPHENYLALANINE) AND METHYLDOPA IN HUNTINGTON'S CHOREA.
    SOURKES TL; PIVNICKI D; BROWN WT; WISEMAN-DISTLER H; MURPHY GF; SANKOFF I; SAINTCYR S
    Psychiatr Neurol (Basel); 1965; 149():7-27. PubMed ID: 14291283
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced extrapyramidal disorders.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
    [No Abstract]   [Full Text] [Related]  

  • 18. PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
    HEATHFIELD KW
    Lancet; 1965 May; 1(7392):957. PubMed ID: 14275722
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICO-ELECTROPHYSIOLOGICAL CORRELATIONS IN FOCAL LESIONS OF THE MOTOR ANALYZER AT THE CORTICO-SUBCORTICAL LEVEL].
    BOLDYREVA GN; BRAZINA NN; PUCHINSKAIA LM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65():61-6. PubMed ID: 14335753
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Longo V; Kemali D; Pacini A; Bertolino A; Lamura G
    Boll Soc Ital Biol Sper; 1971 Aug; 47(15):470-2. PubMed ID: 5158530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.